SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cunningham J, Condon J. Premature mortality in Aboriginal adults in the Northern Territory, 1979–1991. Med. J. Aust. 1996; 165: 30912.
  • 2
    Plant AJ, Condon JR, Durling G. Northern Territory Health Outcomes, Morbidity and Mortality, 1979–1991. NT Dept Health and Human Services, Darwin , NT , 1995.
  • 3
    Hoy WE, Pugsley DJ, Hayhurst B, Mathews JD. Treatment of end stage renal disease in the Top End of the Northern Territory, 1978–1993. Nephrology 1995; 1: 30713.
  • 4
    Hoy WE, Silva D. NT Top End Aboriginal End Stage Renal Disease Data and Projections. Renal Strategy Committee, Territory Health Services, Darwin , NT , 1997.
  • 5
    Census of Population and Housing, 1991. Aboriginal Community Profiles, Small Area Data. Australian Bureau of Statistics, Canberra , 1993.
  • 6
    JainSK (ed.) Trends in Mortality: By Causes of Death in Australia, the States and Territories during 1971–1992, and in Statistical Subdivisions during 1991–1992. ABS Catalogue, no. 3313.0. National Centre for Epidemiology and Population Health and Australian Bureau of Statistics, 1994.
  • 7
    National Diabetes Group. Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 1979; 28: 103957.
  • 8
    Nathan DM, Rosenbaum C, Protasowicki VD. Single void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 1987; 10: 41418.
  • 9
    Nelson RG, Knowler WC, Pettitt DJ et al. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch. Intern. Med. 1991; 151: 17615.
  • 10
    Lemann J, Doumas BT. Proteinuria in health and disease assessed by using the urinary protein/creatinine ratio. Clin. Chem. 1987; 33: 2979.
  • 11
    Woolerton J, Jury DR, Dunn PJ et al. Urine albumin creatinine ratio and clinical correlates in a diabetic population. N.Z. Med. J. 1987; 100: 1304.
  • 12
    Hoy WE, Jim S, Warrington W, Light A, Megill DM. Urinary findings and renal function in adult Navajo Indians, and associations with type 2 diabetes. Am. J. Kidney Dis. 1996; 28: 33949.
  • 13
    Eiser DM. Microalbuminuria and cardiovascular risk factors in Central Australian Aboriginal communities (Bachelor of Medical Science thesis). Dept Medicine, St Vincent's Hospital, Fitzroy , Vic , Aust., 1995.
  • 14
    Guest CS, Ratnaike S, Larkins RG. Albuminuria in Aborigines and Europids of Southeastern Australia. Med. J. Aust. 1993; 159: 3358.
  • 15
    Bangstad HJ, Dahl Jorgensen K, Kjaersgaard R et al. Urinary albumin excretion rate and puberty in nondiabetic children and adolescents. Acta Paediatr. 1993; 82: 85762.
  • 16
    Viberti GC. Interventions based on microalbuminuria screening and low protein diet in the treatment of kidney disease of diabetes mellitus. Am. J. Kidney Dis. 1989; X111: 414.
  • 17
    Consensus Statement. Preventing the kidney disease of diabetes mellitus: Public health perspectives. Am. J. Kidney Dis. 1989; XIII: 26.
  • 18
    Davis AG, Postlethwaite RJ, Price DA et al Urinary albumin excretion in school children. Arch. Dis. Child. 1984; 59: 61530.
  • 19
    Haffner SM, D'Agostino JR, Saad MF et al. Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanic whites. the insulin resistance atherosclerosis study. Diabetes 1996; 45: 7428.
  • 20
    Gebski V, Leung O, McNeil D, Lunn A. Statistical Package for Interactive Data Analysis, Version 6. Statistical Computing Laboratory, Macquarie University, NSW, Australia , 1992.
  • 21
    Hoy WE, Pugsley DJ, Norman RJ, Hayhurst BG. A health profile of adults in a Northern Territory Aboriginal community, with an emphasis on preventable morbidities. Aust. N.Z. J. Public Health 1997; 21: 1216.
  • 22
    Kile E. Relationships between low birth weight, morbidity and mortality in Aboriginal people (Bachelor of Medical Science thesis). Monash University and the Menzies School of Health Research, Darwin , 1995.
  • 23
    Sayers SM, Powers JR. Birth size of Australian Aboriginal babies. Med. J. Aust. 1993; 159: 58691.
  • 24
    Sayers SM. Low birth weight in Aboriginal babies. Aust. N.Z. J. Obstet. Gynaecol. 1997; 37: 1312.
  • 25
    Sayers SM, Powers JR. Risk factors for Aboriginal low birth weight, intrauterine growth retardation and preterm births in the Darwin Health Region. Aust. N.Z. J. Public Health 1998 (in press).
  • 26
    Blair E, Morich P, Stanley F. Why do Aboriginal newborns weight less? Gestational age, at delivery: estimation, distribution and determinants. Aust. N.Z. J. Obstet. Gynaecol. 1994; 34: 15863.
  • 27
    Villar J, Belizan JM. the relative contribution of prematurity and fetal growth retardation to low birth weight in developing and developed societies. Am. J. Obstet. Gynecol. 1982; 143: 7938.
  • 28
    WHO Collaborative Study. Maternal anthropometry and pregnancy outcomes. Bull. World Health Organ. 1995; 73: 1517.
  • 29
    Walker KA Trends in birth weights and infant weights, and relationships between early undernutrition, skin lesions, streptococcal disease and renal disease in an Australian Aboriginal community (Bachelor of Medical Science thesis). Melbourne University and Menzies School of Health Research, 1996.
  • 30
    Hoy WE, Mathews JD, Kile E, Rees M. A new dimension to the Barker hypothesis: Low birth weight predisposes to renal disease: findings in an Australian Aboriginal community. Lancet 1998 (in press).
  • 31
    Megill DM, Hoy WE. Risk factors for renal disease in a Native American community Transplant. Proc. 1989; 21: 39025.
  • 32
    Kawamura T, Ohta T, Ohno Y et al. Significance of urinalysis for subsequent kidney and urinary tract disorders in mass screening of adults. Intern. Med. 1995; 34: 47580.
  • 33
    van Buynder PG, Gaggin JA, Mathews JD. Renal disease patterns in Aboriginal Australians. Med. J. Aust. 1993; 159: 827.
  • 34
    Lopes AAS, Port FK. the low birth weight hypothesis is a plausible explanation for the Black/White differences in hypertension, non-insulin dependent diabetes and end stage renal disease. Am. J. Kidney Dis. 1995; 25: 3506.
  • 35
    Barker DJP. Mothers, Babies and Disease In Later Life. BMJ Publishing Group, Tavistock Square, 1994.
  • 36
    Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am. J. Kidney Dis. 1994; 23: 1715.
  • 37
    Gogna NK, Nossar V, Walker AC. Epidemic of acute post-streptococcal glomerulonephritis in Aboriginal communities. Med. J. Aust. 1983; 1: 646.
  • 38
    Rodriguez-Iturbe B. Acute endocapillary glomerulonephritis. In: CameronS, DavisonAM, GrunfelJP, KerrD, RitzE (eds) Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford , 1992.
  • 39
    Rodriguez-Iturbe B, Herrera J, Garcia R. Response to acute protein load in kidney donor and in apparently normal postacute glomerulonephritis patients: evidence for glomerular hyperfiltration. Lancet 1985; ii: 4614.
  • 40
    Buzio C, Allegri L, Mutti A, Perazolli F, Bergamaschi E. Significance of albuminuria on the follow-up of acute poststreptococcal glomerulonephritis. Clin. Nephrol. 1994; 41: 25964.
  • 41
    Gallo GR, Feiner HD, Steel JM, Schacht RG, Gluck MC, Baldwin DS. Role of intravascular sclerosis in progression of poststreptococcal glomerulonephritis. Clin. Nephrol. 1980; 13: 44957.
  • 42
    Gardiner Dl, Sriprakash KS Molecular epidemiology of impetiginous group A streptococcal infections in Aboriginal communities of Northern Australia. J. Clin. Microbiol. 1996; 34: 144852.
  • 43
    Relf WA, Martin DR, Sripakash KS. Antigenic diversity within a family of M-proteins from group A streptococci: evidence for the role of frameshift and compensatory mutation. Gene 1994; 144: 2530.
  • 44
    Sarker MH, Chowdhury RI, Rashid HU. Study of proteinuria in a community. Bangladesh Med. Res. Counc. Bull. 1991; 17: 417.
  • 45
    Davison AM. Infection-associated glomerulonephritis. In: CameronS, DavisonAM, GrunfelJP, KerrD, RitzE (eds) Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford , 1992.
  • 46
    Abboud HE. Growth factors in glomerulonephritis. Kidney Int. 1993; 43: 25267.
  • 47
    Gilbert RE, Cooper ME, Jerums G. Extracellular matrix, growth factors and their interactions in the pathogenesis of diabetic kidney disease. Nephrology 1996; 2: 291303.
  • 48
    Reaven GM. Insulin resistance and compensatory hyperinsulinemia; role in hyper-tension, dyslipidemia, and coronary artery disease. Am. Heart J. 1991; 121: 12838.
  • 49
    Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in noninsulin dependent diabetes: a 10 year follow up study of 503 patients. Diabet. Med. 1988; 5: 12634.
  • 50
    Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Lancet 1988; ii: 5303.
  • 51
    Howard DM, Davis J, Pugsley DJ, Seymour AM, Hoy WE. Morphologic correlates of renal disease in a high risk Australian Aboriginal community. In: Proceedings of 32nd Annual Meeting, Australian and New Zealand Society of Nephrology, March 58, 1996.
  • 52
    Lloyd ML, Moore L, Pugsley DJ, Seymour AM. Renal disease in an Australian Aboriginal population: a pathologic study. Nephrology 1996; 2: 31522.
  • 53
    Bertram JF. Analysing renal glomeruli with the new stereology. Int. Rev. Cytol. 1995; 161: 11192.
  • 54
    Hoy WE, Bertram JH, Young R et al. Does glomerulomegaly mark the susceptibility of high risk populations to renal disease Am. J. Kidney Dis. (Submitted).
  • 55
    Schmidt K, Pesce C, Liu QL et al. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J. Am. Soc. Nephrol. 1992; 3: 22935.
  • 56
    Pesce CM, Schmidt K, Fogo A et al. Glomerular size and the incidence of renal disease in African Americans and Caucasians. J. Nephrol. 1994; 7: 3558.
  • 57
    Perneger TV, Klag MJ, Whelton PK. Race and socioeconomic status in hypertension and renal disease. Curr. Opin. Nephrol. Hypertens. 1995; 4: 2359.
  • 58
    Hoy WE. Markers for cardiovascular and renal morbidity; expectations for an intervention program in an Australian Aboriginal community. Clin. Exp. Pharmacol. Physiol. 1996; 23 (Suppl. 1): S337.
  • 59
    Hoy WE. Screening for renal disease and other chronic diseases in Aboriginal adults, and preliminary experience of a medical intervention program. Nephrology 1998; 4 (Suppl.): S906.